On Friday night during Jim Cramer's Mad Money program, he identified another high flier this year, InMode (INMD) , which has soared about 213% this year. Cramer said he still loves this company's medical aesthetics technology that doesn't require invasive surgery. He loves that the company is profitable with accelerating revenue growth. But you can't be greedy, and should lock in some of your gains before the end of the year.
More from Investing
It feels like these companies are casting a wide net, but it makes sense to file at the beginning of this mushroom mania.
Short selling is a powerful tool, but it is not just the inverse of going long and requires a very different mindset to do it effectively.
I believe the markets are headed lower - probably not in a straight line or as steep as the last few days, but in a saw tooth fashion lower.
It is premature to declare that the worst is over, but the intensity of the selling will go a long way toward helping a bottom to form.